These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36797432)

  • 1. Evidential requirements for the regulatory hazard and risk assessment of respiratory sensitisers: methyl methacrylate as an example.
    Meek B; Bridges JW; Fasey A; Sauer UG
    Arch Toxicol; 2023 Apr; 97(4):931-946. PubMed ID: 36797432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence.
    Meek ME; Palermo CM; Bachman AN; North CM; Jeffrey Lewis R
    J Appl Toxicol; 2014 Jun; 34(6):595-606. PubMed ID: 24777878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the potency of respiratory allergens: uncertainties and challenges.
    Basketter DA; Kimber I
    Regul Toxicol Pharmacol; 2011 Dec; 61(3):365-72. PubMed ID: 22019813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl methacrylate and respiratory sensitisation: a comprehensive review.
    Pemberton MA; Kimber I
    Crit Rev Toxicol; 2022 Feb; 52(2):139-166. PubMed ID: 35607993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.
    Becker RA; Ankley GT; Edwards SW; Kennedy SW; Linkov I; Meek B; Sachana M; Segner H; Van Der Burg B; Villeneuve DL; Watanabe H; Barton-Maclaren TS
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):514-37. PubMed ID: 25863193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the skin sensitising potency of the lower alkyl methacrylate esters.
    Kimber I; Pemberton MA
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):24-36. PubMed ID: 24956587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesis-based weight-of-evidence evaluation of methyl methacrylate olfactory effects in humans and derivation of an occupational exposure level.
    Pemberton M; Bailey LA; Rhomberg LR
    Regul Toxicol Pharmacol; 2013 Jul; 66(2):217-33. PubMed ID: 23583434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
    Vandenberg LN; Ågerstrand M; Beronius A; Beausoleil C; Bergman Å; Bero LA; Bornehag CG; Boyer CS; Cooper GS; Cotgreave I; Gee D; Grandjean P; Guyton KZ; Hass U; Heindel JJ; Jobling S; Kidd KA; Kortenkamp A; Macleod MR; Martin OV; Norinder U; Scheringer M; Thayer KA; Toppari J; Whaley P; Woodruff TJ; Rudén C
    Environ Health; 2016 Jul; 15(1):74. PubMed ID: 27412149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of chemicals as respiratory allergens based on human data: Requirements and practical considerations.
    Pemberton MA; Kimber I
    Regul Toxicol Pharmacol; 2021 Jul; 123():104925. PubMed ID: 33831493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approach to weight-of-evidence assessment of ecotoxicological effects in regulatory decision-making.
    Hall AT; Belanger SE; Guiney PD; Galay-Burgos M; Maack G; Stubblefield W; Martin O
    Integr Environ Assess Manag; 2017 Jul; 13(4):573-579. PubMed ID: 28383801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis.
    Meek ME; Boobis A; Cote I; Dellarco V; Fotakis G; Munn S; Seed J; Vickers C
    J Appl Toxicol; 2014 Jan; 34(1):1-18. PubMed ID: 24166207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thresholds in chemical respiratory sensitisation.
    Cochrane SA; Arts JHE; Ehnes C; Hindle S; Hollnagel HM; Poole A; Suto H; Kimber I
    Toxicology; 2015 Jul; 333():179-194. PubMed ID: 25963507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The OSIRIS Weight of Evidence approach: ITS for skin sensitisation.
    Rorije E; Aldenberg T; Buist H; Kroese D; Schüürmann G
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):146-56. PubMed ID: 23792263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insufficient respiratory hazard identification in the safety data sheets for cleaning and disinfection products used in healthcare organisations across England and Wales.
    Lee S; Povey AC; Seed MJ; van Tongeren M
    Occup Environ Med; 2021 Apr; 78(4):293-295. PubMed ID: 33563606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Weight of Evidence approach to classify nanomaterials according to the EU Classification, Labelling and Packaging Regulation criteria.
    Basei G; Zabeo A; Rasmussen K; Tsiliki G; Hristozov D
    NanoImpact; 2021 Oct; 24():100359. PubMed ID: 35559818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.